The initial success of Viagra undeniably revolutionized the pharmaceutical landscape, but betting in companies strongly reliant on off-patent versions presents a uncertain picture. Despite early profits were substantial, the end of patents and the emergence of less expensive alternatives have eroded sales. Therefore, a thorough evaluation of curren